Literature DB >> 23719237

Body mass index, immune status, and virological control in HIV-infected men who have sex with men.

Aaron J Blashill1, Kenneth H Mayer, Heidi M Crane, Chris Grasso, Steven A Safren.   

Abstract

BACKGROUND AND AIMS: Prior cross-sectional studies have found inconsistent relationships between body mass index (BMI) and disease progression in HIV-infected individuals.
METHODS: Cross-sectional and longitudinal analyses were conducted on data from a sample of 864 HIV-infected men who have sex with men (MSM) obtained from a large, nationally distributed HIV clinical cohort.
RESULTS: Of the 864 HIV-infected MSM, 394 (46%) were of normal weight, 363 (42%) were overweight, and 107 (12%) were obese at baseline. The baseline CD4 count was 493 (standard error [SE] = 9), with viral load (log10) = 2.4 (SE = .04), and 561 (65%) were virologically suppressed. Over time, controlling for viral load, highly active antiretroviral therapy (HAART) adherence, age, and race/ethnicity, overweight and obese HIV-infected men possessed higher CD4 counts than that of normal weight HIV-infected men. Further, overweight and obese men possessed lower viral loads than that of normal weight HIV-infected men.
CONCLUSIONS: For HIV-infected MSM, in this longitudinal cohort study, possessing a heavier than normal BMI is longitudinally associated with improved immunological health.

Entities:  

Keywords:  CD4; HIV/AIDS; body mass index; obesity; viral load

Mesh:

Substances:

Year:  2013        PMID: 23719237      PMCID: PMC4259246          DOI: 10.1177/2325957413488182

Source DB:  PubMed          Journal:  J Int Assoc Provid AIDS Care        ISSN: 2325-9574


  25 in total

1.  Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy.

Authors:  Jennifer H Lee; Jean L Chan; Epaminondas Sourlas; Vassilios Raptopoulos; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2006-04-24       Impact factor: 5.958

Review 2.  Medical consequences of obesity.

Authors:  George A Bray
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

3.  When obesity is desirable: a longitudinal study of the Miami HIV-1-infected drug abusers (MIDAS) cohort.

Authors:  G Shor-Posner; A Campa; G Zhang; N Persaud; M J Miguez-Burbano; J Quesada; M A Fletcher; J B Page; M K Baum
Journal:  J Acquir Immune Defic Syndr       Date:  2000-01-01       Impact factor: 3.731

Review 4.  Obesity and infection.

Authors:  Matthew E Falagas; Maria Kompoti
Journal:  Lancet Infect Dis       Date:  2006-07       Impact factor: 25.071

5.  Leptin in obesity.

Authors:  T I Sørensen; S Echwald; J C Holm
Journal:  BMJ       Date:  1996-10-19

6.  Prevalence and predictive value of overweight in an urban HIV care clinic.

Authors:  J Shuter; C J Chang; R S Klein
Journal:  J Acquir Immune Defic Syndr       Date:  2001-03-01       Impact factor: 3.731

7.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

8.  Preferential effects of leptin on CD4 T cells in central and peripheral immune system are critically linked to the expression of leptin receptor.

Authors:  So Yong Kim; Ju Hyun Lim; Sung Won Choi; Miyoung Kim; Seong-Tae Kim; Min-Seon Kim; You Sook Cho; Eunyoung Chun; Ki-Young Lee
Journal:  Biochem Biophys Res Commun       Date:  2010-03-17       Impact factor: 3.575

9.  Overweight and human immunodeficiency virus (HIV) progression in women: associations HIV disease progression and changes in body mass index in women in the HIV epidemiology research study cohort.

Authors:  Clara Y Jones; Joseph W Hogan; Brad Snyder; Robert S Klein; Anne Rompalo; Paula Schuman; Charles C Carpenter
Journal:  Clin Infect Dis       Date:  2003       Impact factor: 9.079

10.  Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency.

Authors:  I Sadaf Farooqi; Giuseppe Matarese; Graham M Lord; Julia M Keogh; Elizabeth Lawrence; Chizo Agwu; Veronica Sanna; Susan A Jebb; Francesco Perna; Silvia Fontana; Robert I Lechler; Alex M DePaoli; Stephen O'Rahilly
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

View more
  19 in total

1.  Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis.

Authors:  Lesley S Park; Raúl U Hernández-Ramírez; Michael J Silverberg; Kristina Crothers; Robert Dubrow
Journal:  AIDS       Date:  2016-01       Impact factor: 4.177

2.  The Relationship Between Caffeine Intake and Immunological and Virological Markers of HIV Disease Progression in Miami Adult Studies on HIV Cohort.

Authors:  Venkataraghavan Ramamoorthy; Adriana Campa; Muni Rubens; Sabrina S Martinez; Christina Fleetwood; Tiffanie Stewart; Juan P Liuzzi; Florence George; Hafiz Khan; Yinghui Li; Marianna K Baum
Journal:  Viral Immunol       Date:  2017-04-14       Impact factor: 2.257

3.  Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study.

Authors:  Vincent Madelain; Minh P Le; Karen Champenois; Charlotte Charpentier; Roland Landman; Veronique Joly; Patrick Yeni; Diane Descamps; Yazdan Yazdanpanah; Gilles Peytavin
Journal:  J Antimicrob Chemother       Date:  2017-04-01       Impact factor: 5.790

4.  Growth curve modelling to determine distinct BMI trajectory groups in HIV-positive adults on antiretroviral therapy in South Africa.

Authors:  Alana T Brennan; Kaitlyn M Berry; Sydney Rosen; Andrew Stokes; Nigel J Crowther; Jaya George; Frederick Raal; Naseem Cassim; Ian Sanne; Lawrence Long; Matthew P Fox
Journal:  AIDS       Date:  2019-11-01       Impact factor: 4.177

Review 5.  Metabolic consequences of HIV: pathogenic insights.

Authors:  Amanda L Willig; E Turner Overton
Journal:  Curr HIV/AIDS Rep       Date:  2014-03       Impact factor: 5.071

6.  Caffeine Intake and Its Association with Body Composition Measures and Macronutrient Intakes in People Living with HIV in the Miami Adult Studies on HIV Cohort.

Authors:  Venkataraghavan Ramamoorthy; Adriana Campa; Muni Rubens; Sabrina S Martinez; Christina Fleetwood; Tiffanie Stewart; Juan P Liuzzi; Florence George; Hafiz Khan; Yinghui Li; Marianna Baum
Journal:  J Caffeine Adenosine Res       Date:  2018-03-01

7.  Body mass index and early CD4 T-cell recovery among adults initiating antiretroviral therapy in North America, 1998-2010.

Authors:  J R Koethe; C A Jenkins; B Lau; B E Shepherd; M J Silverberg; T T Brown; A J Blashill; A Anema; A Willig; S Stinnette; S Napravnik; J Gill; H M Crane; T R Sterling
Journal:  HIV Med       Date:  2015-05-11       Impact factor: 3.180

8.  Higher Body Mass Index Is Associated With Greater Proportions of Effector CD8+ T Cells Expressing CD57 in Women Living With HIV.

Authors:  Michael J A Reid; Sanjiv M Baxi; Lila A Sheira; Alan L Landay; Edward A Frongillo; Adebola Adedimeji; Mardge H Cohen; Eryka Wentz; Deborah R Gustafson; Daniel Merenstein; Peter W Hunt; Phyllis C Tien; Sheri D Weiser
Journal:  J Acquir Immune Defic Syndr       Date:  2017-08-15       Impact factor: 3.731

9.  Weight change after antiretroviral therapy and mortality.

Authors:  Bianca Yuh; Janet Tate; Adeel A Butt; Kristina Crothers; Matthew Freiberg; David Leaf; Mary Logeais; David Rimland; Maria C Rodriguez-Barradas; Christopher Ruser; Amy C Justice
Journal:  Clin Infect Dis       Date:  2015-03-11       Impact factor: 9.079

Review 10.  Ageing and inflammation in patients with HIV infection.

Authors:  M Nasi; S De Biasi; L Gibellini; E Bianchini; S Pecorini; V Bacca; G Guaraldi; C Mussini; M Pinti; A Cossarizza
Journal:  Clin Exp Immunol       Date:  2016-08-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.